Avidity Biosciences (RNA) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Avidity Biosciences (RNA) over the last 5 years, with Dec 2024 value amounting to $111.6 million.

  • Avidity Biosciences' Shares Outstanding (Diluted Average) rose 11.77% to $137.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.9 million, marking a year-over-year increase of 11.77%. This contributed to the annual value of $111.6 million for FY2024, which is 52.83% up from last year.
  • According to the latest figures from FY2024, Avidity Biosciences' Shares Outstanding (Diluted Average) is $111.6 million, which was up 52.83% from $73.0 million recorded in FY2023.
  • Avidity Biosciences' Shares Outstanding (Diluted Average)'s 5-year high stood at $111.6 million during FY2024, with a 5-year trough of $21.7 million in FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $73.0 million (2023), whereas its average is $78.9 million.
  • Data for Avidity Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY soared of 91.24% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Avidity Biosciences' Shares Outstanding (Diluted Average) stood at $21.7 million in 2020, then soared by 91.24% to $41.4 million in 2021, then increased by 25.91% to $52.2 million in 2022, then skyrocketed by 39.97% to $73.0 million in 2023, then spiked by 52.83% to $111.6 million in 2024.